LAUREN BLAKLEY: Open Payments
NPI 1326609074 · JACKSBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$977 in 45 payments from 12 companies in 2025. Trend: 2023 $938 · 2024 $1,624 · 2025 $977
Food & beverage: $855Education: $122
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 15 | $197 |
| Regeneron Healthcare Solutions, Inc. | 6 | $147 |
| Genentech USA, Inc. | 4 | $98 |
| GENZYME CORPORATION | 4 | $96 |
| SANOFI-AVENTIS U.S. LLC | 1 | $88 |
| AstraZeneca Pharmaceuticals LP | 4 | $73 |
| Amgen Inc. | 3 | $68 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $51 |
| Optinose US, Inc. | 2 | $45 |
Products named: DUPIXENT, TRELEGY ELLIPTA, Xolair, NUCALA, NEFFY, TEZSPIRE, Xhance, AIRSUPRA.
Industry payments across TN — which companies pay providers there.
